ANI Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANIP and other ETFs, options, and stocks.

About ANIP

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. 

CEO
Nikhil Lalwani
CEONikhil Lalwani
Employees
897
Employees897
Headquarters
Baudette, Minnesota
HeadquartersBaudette, Minnesota
Founded
1996
Founded1996
Employees
897
Employees897

ANIP Key Statistics

Market cap
1.90B
Market cap1.90B
Price-Earnings ratio
46.78
Price-Earnings ratio46.78
Dividend yield
Dividend yield
Average volume
576.99K
Average volume576.99K
High today
$87.01
High today$87.01
Low today
$79.19
Low today$79.19
Open price
$82.48
Open price$82.48
Volume
1.08M
Volume1.08M
52 Week high
$99.50
52 Week high$99.50
52 Week low
$52.74
52 Week low$52.74

Stock Snapshot

As of today, ANI Pharmaceuticals(ANIP) shares are valued at $84.35. The company's market cap stands at 1.9B, with a P/E ratio of 46.78.

As of 2026-01-13, ANI Pharmaceuticals(ANIP) stock has fluctuated between $79.19 and $87.01. The current price stands at $84.35, placing the stock +6.5% above today's low and -3.1% off the high.

The ANI Pharmaceuticals(ANIP)'s current trading volume is 1.08M, compared to an average daily volume of 576.99K.

During the past year, ANI Pharmaceuticals(ANIP) stock moved between $52.74 at its lowest and $99.50 at its peak.

During the past year, ANI Pharmaceuticals(ANIP) stock moved between $52.74 at its lowest and $99.50 at its peak.

ANIP News

Simply Wall St 4d
Do Strong 2025 Rare Disease Results Reshape the Bull Case for ANI Pharmaceuticals?

ANI Pharmaceuticals recently announced that CEO Nikhil Lalwani would present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026, with the...

Do Strong 2025 Rare Disease Results Reshape the Bull Case for ANI Pharmaceuticals?

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own ANIP. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.